Autopsy report · NCT02864628

RSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults.

“Protocol was withdrawn from IND”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Bavarian Nordic

Sponsor type

Industry

Conditions

Respiratory Syncytial Virus Infections

Interventions

MVA-BN-RSV; Placebo

Participants

0

Trials that died the same way

• A Clinical Trial to Study Single- and Multiple- Doses of GSM-779690T in Healthy Participants
  “The protocol is being withdrawn prior to enrollment due to a redesign of the study approach under the existing IND.” (68% match in meaning)
• EXCOR® Pediatric VAD Anticoagulation IDE
  “PI withdrew protocol” (66% match in meaning)
• Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma
  “IND withdrawn” (66% match in meaning)
• Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)
  “Other - Protocol moved to Disapproved” (62% match in meaning)
• Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis
  “The IND has been withdrawn from FDA” (61% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.